LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,316,350 | -4.9% | 592,417 | 0.0% | 0.21% | -21.0% |
| Q2 2023 | $2,434,834 | +104.5% | 592,417 | 0.0% | 0.27% | +120.3% |
| Q1 2023 | $1,190,758 | -36.0% | 592,417 | 0.0% | 0.12% | -53.9% |
| Q4 2022 | $1,860,189 | -37.3% | 592,417 | 0.0% | 0.27% | -33.7% |
| Q3 2022 | $2,968,000 | -11.3% | 592,417 | 0.0% | 0.40% | -22.8% |
| Q2 2022 | $3,347,000 | +7506.8% | 592,417 | +5824.2% | 0.52% | +12950.0% |
| Q4 2021 | $44,000 | -97.8% | 10,000 | -95.4% | 0.00% | -98.7% |
| Q3 2021 | $1,967,000 | +33.8% | 215,576 | +17.8% | 0.31% | +35.8% |
| Q2 2021 | $1,470,000 | -73.3% | 183,076 | -61.5% | 0.23% | -77.3% |
| Q1 2021 | $5,515,000 | +6.1% | 475,814 | +4.3% | 0.99% | +44.9% |
| Q4 2020 | $5,199,000 | +320.3% | 456,138 | +312.2% | 0.69% | +4.6% |
| Q3 2020 | $1,237,000 | +80.1% | 110,670 | +82.4% | 0.66% | +67.3% |
| Q2 2020 | $687,000 | – | 60,670 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |